Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Details) - Schedule of diluted net loss per share

v3.22.2.2
Net Loss per Share (Details) - Schedule of diluted net loss per share - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 4,098,867 3,486,831 4,098,867 3,486,831
Stock options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 118,388 118,388 118,388 118,388
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,567,720 1,050,104 1,567,720 1,050,104
Restricted Stock Units [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,412,759 2,318,339 2,412,759 2,318,339